KR100858947B1 - 면역효과기 화합물을 사용하는 감염성 질환 및 기타질환의 예방학적 및 치료학적 처치 - Google Patents
면역효과기 화합물을 사용하는 감염성 질환 및 기타질환의 예방학적 및 치료학적 처치 Download PDFInfo
- Publication number
- KR100858947B1 KR100858947B1 KR1020047011969A KR20047011969A KR100858947B1 KR 100858947 B1 KR100858947 B1 KR 100858947B1 KR 1020047011969 A KR1020047011969 A KR 1020047011969A KR 20047011969 A KR20047011969 A KR 20047011969A KR 100858947 B1 KR100858947 B1 KR 100858947B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- pharmaceutical composition
- group
- compounds
- independently
- Prior art date
Links
- 0 CCCCCCCCCCCC(*)CC(C=*C1C(*C(CC(CCCCCCCCCCC)O*)=O)[C@](*)C(C*)O*1)=O Chemical compound CCCCCCCCCCCC(*)CC(C=*C1C(*C(CC(CCCCCCCCCCC)O*)=O)[C@](*)C(C*)O*1)=O 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (63)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 리스테리아, 인플루엔자, 폐렴, 만성 간염, 인간 유두종 바이러스, 구강 또는 질내 칸디다증, 치주위 질환, 진균 전이증식에 의한 만성 비부비동염, 천식, 아토피성 피부염, 계절성 알레르기 질환, 만성 비부비동염, 염증성 장 질환, 류마티스성 관절염, 만성 관절염, 다발성 경화증 및 건선을 완화시키거나 또는 실질적으로 예방하는 약학 조성물로서,하기 화학식 Ⅰ을 갖는 하나 이상의 화합물 및 이의 약학적으로 허용가능한 염과 약학적으로 허용 가능한 담체를 포함하는, 외인성 항원의 부재하에 제제화 및 투여되는 약학 조성물:화학식 Ⅰ상기 식중,X는 -O- 및 -NH-로 이루어진 군으로부터 선택되는 일원이고;Y는 -O- 및 -S-로 이루어진 군으로부터 선택되는 일원이며;R1, R2 및 R3은 각각 독립적으로 (C2-C20)아실로 이루어진 군으로부터 선택되는 일원이고;R4는 -H 및 -PO3R7R8[식중, R7 및 R8은 각각 독립적으로 -H 및 (C1-C4)지방족 기로 이루어진 군으로부터 선택되는 일원임]으로 이루어진 군으로부터 선택되는 일원이며;R5는 -H, -CH3 및 -PO3R9R10[식중, R9 및 R10은 각각 독립적으로 -H 및 (C1-C4)지방족기로 이루어진 군으로부터 선택되는 일원임]으로 이루어진 군으로부터 선택되는 일원이고;R6은 H, OH, (C1-C4)옥시지방족기, -PO3R11R12, -OPO3R11R12, -SO3R11, -OSO3R11, -NR11R12, -SR11, -CN, -NO2, -CHO, -CO2R11 및 -CONR11R12[식중, R11 및 R12는 각각 독립적으로 H 및 (C1-C4)지방족기로부터 선택됨]로부터 선택되는 것이되;단, R4 및 R5중 어느 하나가 인-함유기이고 R4가 -PO3R7R8이면, R5는 -PO3R9R10을 제외한 것이며;"*1", "*2" , "*3" 및 "**"는 키랄 중심을 나타내고;n, m, p 및 q는 각각 독립적으로 0∼6의 정수이되, 단 p와 m의 합은 0∼6이다.
- 제45항에 있어서, 상기 X 및 Y는 -O-이고, R4는 PO3R7R8이며, R5 및 R6은 H이고, n, m, p 및 q는 0∼3의 정수인 것인 약학 조성물.
- 제46항에 있어서, 상기 R7 및 R8은 -H인 것인 약학 조성물.
- 제46항에 있어서, 상기 n, m, p 및 q는 0∼2인 것인 약학 조성물.
- 제47항에 있어서, 상기 n은 1이고, m은 2이며, p 및 q는 0인 것인 약학 조성물.
- 제45항에 있어서, 상기 R1, R2 및 R3은 각각 C6-C14아실인 것인 약학 조성물.
- 제45항에 있어서, 상기 R1, R2 및 R3은 각각 C6-C12아실인 것인 약학 조성물.
- 제49항에 있어서, 상기 R1, R2 및 R3은 각각 데카노일 잔기인 것인 약학 조성물.
- 제49항에 있어서, 상기 R1, R2 및 R3은 각각 도데카노일 잔기인 것인 약학 조성물.
- 제49항에 있어서, 상기 R1, R2 및 R3은 각각 테트라데카노일 잔기인 것인 약학 조성물.
- 제49항에 있어서, 상기 *1, *2 및 *3은 R 입체배열인 것인 약학 조성물.
- 제49항에 있어서, 상기 Y는 수평 위치인 것인 약학 조성물.
- 제49항에 있어서, 상기 **는 S 입체배열인 것인 약학 조성물.
- 제49항에 있어서, 상기 *1, *2 및 *3은 R 입체배열이고, Y는 수평 위치이며, **는 S 입체배열인 것인 약학 조성물.
- 제45항에 있어서, 하나 이상의 계면활성제를 더 포함하는 것인 약학 조성물.
- 제59항에 있어서, 상기 하나 이상의 계면활성제는 디미리스토일 포스파티딜 글리세롤(DPMG), 디팔미토일 포스파티딜 글리세롤(DPPG), 디스테아로일 포스파티딜 글리세롤(DSPG), 디미리스토일 포스파티딜콜린(DPMC), 디팔미토일 포스파티딜콜린(DPPC), 디스테아로일 포스파티딜콜린(DSPC), 디미리스토일 포스파티딘산(DPMA), 디팔미토일 포스파티딘산(DPPA), 디스테아로일 포스파티딘산(DSPA), 디미리스토일 포스파티딜 에탄올아민(DPME), 디팔미토일 포스파티딜 에탄올아민(DPPE) 및 디스테아로일 포스파티딜 에탄올아민(DSPE)으로 이루어진 군으로부터 선택되는 것인 약학 조성물.
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/003581 WO2003066065A1 (en) | 2002-02-04 | 2002-02-04 | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040081174A KR20040081174A (ko) | 2004-09-20 |
KR100858947B1 true KR100858947B1 (ko) | 2008-09-17 |
Family
ID=27732076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047011969A KR100858947B1 (ko) | 2002-02-04 | 2002-02-04 | 면역효과기 화합물을 사용하는 감염성 질환 및 기타질환의 예방학적 및 치료학적 처치 |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1482955B1 (ko) |
JP (1) | JP2005523902A (ko) |
KR (1) | KR100858947B1 (ko) |
CN (2) | CN1622812A (ko) |
AU (1) | AU2002255513B2 (ko) |
BR (1) | BR0215583A (ko) |
CA (1) | CA2474402C (ko) |
CZ (1) | CZ2004861A3 (ko) |
ES (1) | ES2453903T3 (ko) |
HU (1) | HUP0402570A3 (ko) |
IL (1) | IL163305A (ko) |
MX (1) | MXPA04007491A (ko) |
NO (1) | NO20043693L (ko) |
NZ (1) | NZ534592A (ko) |
WO (1) | WO2003066065A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60234386D1 (de) * | 2002-02-04 | 2009-12-24 | Corixa Corp | Neue immuneffektor-verbindungen |
US6911434B2 (en) | 2002-02-04 | 2005-06-28 | Corixa Corporation | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
WO2006093352A1 (ja) * | 2005-03-04 | 2006-09-08 | Riken | 環状構造を有する化合物及びその用途 |
CN105131051B (zh) | 2009-06-05 | 2020-07-10 | 传染性疾病研究院 | 合成的吡喃葡萄糖脂佐剂 |
GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
US20220273789A1 (en) | 2019-07-21 | 2022-09-01 | Glaxosmithkline Biologicals Sa | Therapeutic viral vaccine |
US20230234992A1 (en) | 2020-06-05 | 2023-07-27 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
EP4032547A1 (en) | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Hsv1 fce derived fragements for the treatment of hsv |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5004261B2 (ja) * | 2000-05-19 | 2012-08-22 | コリクサ コーポレイション | 単糖類及び二糖類に基づく化合物を用いた感染症及び他の疾患の予防的並びに治療的な処置 |
EP1311522B1 (en) | 2000-08-04 | 2006-03-22 | Corixa Corporation | New immunoeffector compounds |
DE60234386D1 (de) * | 2002-02-04 | 2009-12-24 | Corixa Corp | Neue immuneffektor-verbindungen |
-
2002
- 2002-02-04 WO PCT/US2002/003581 patent/WO2003066065A1/en active Application Filing
- 2002-02-04 CZ CZ2004861A patent/CZ2004861A3/cs unknown
- 2002-02-04 CN CNA028284356A patent/CN1622812A/zh active Pending
- 2002-02-04 ES ES02724914.3T patent/ES2453903T3/es not_active Expired - Lifetime
- 2002-02-04 IL IL16330502A patent/IL163305A/xx unknown
- 2002-02-04 BR BR0215583-4A patent/BR0215583A/pt not_active Application Discontinuation
- 2002-02-04 CA CA2474402A patent/CA2474402C/en not_active Expired - Lifetime
- 2002-02-04 KR KR1020047011969A patent/KR100858947B1/ko active IP Right Grant
- 2002-02-04 HU HU0402570A patent/HUP0402570A3/hu unknown
- 2002-02-04 EP EP02724914.3A patent/EP1482955B1/en not_active Expired - Lifetime
- 2002-02-04 AU AU2002255513A patent/AU2002255513B2/en not_active Expired
- 2002-02-04 JP JP2003565489A patent/JP2005523902A/ja not_active Withdrawn
- 2002-02-04 NZ NZ534592A patent/NZ534592A/en not_active IP Right Cessation
- 2002-02-04 CN CN200710161297XA patent/CN101138566B/zh not_active Expired - Lifetime
- 2002-02-04 MX MXPA04007491A patent/MXPA04007491A/es active IP Right Grant
-
2004
- 2004-09-03 NO NO20043693A patent/NO20043693L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
Also Published As
Publication number | Publication date |
---|---|
ES2453903T3 (es) | 2014-04-08 |
EP1482955A1 (en) | 2004-12-08 |
WO2003066065A1 (en) | 2003-08-14 |
CA2474402A1 (en) | 2003-08-14 |
CA2474402C (en) | 2012-09-11 |
EP1482955B1 (en) | 2013-12-25 |
HUP0402570A2 (hu) | 2005-10-28 |
CN101138566A (zh) | 2008-03-12 |
BR0215583A (pt) | 2004-12-21 |
KR20040081174A (ko) | 2004-09-20 |
HUP0402570A3 (en) | 2006-02-28 |
IL163305A (en) | 2010-10-31 |
CN101138566B (zh) | 2012-05-23 |
NZ534592A (en) | 2006-06-30 |
EP1482955A4 (en) | 2008-08-06 |
JP2005523902A (ja) | 2005-08-11 |
MXPA04007491A (es) | 2004-11-10 |
NO20043693L (no) | 2004-09-03 |
AU2002255513A1 (en) | 2003-09-02 |
CZ2004861A3 (cs) | 2004-12-15 |
AU2002255513B2 (en) | 2008-03-06 |
CN1622812A (zh) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6911434B2 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds | |
AU2007202117B2 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds | |
AU2001269695A1 (en) | Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-based compounds | |
US8318697B2 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds | |
KR100858947B1 (ko) | 면역효과기 화합물을 사용하는 감염성 질환 및 기타질환의 예방학적 및 치료학적 처치 | |
KR20040083433A (ko) | 신규 면역효과기 화합물 | |
RU2288723C2 (ru) | Профилактическое и терапевтическое лечение инфекционных и других заболеваний с помощью иммуноэффективных соединений | |
US20080119415A1 (en) | Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds | |
ZA200209438B (en) | Prophylactic and therapeutic treatment of infectious autoimmune and allergic diseases with mono and disaccharide-base compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120830 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130830 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140828 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160629 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170629 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190624 Year of fee payment: 12 |